Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies

Danaher Partners with the University of Pennsylvania’s Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies WASHINGTON, March 7, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation. The multi-year... Read more

Thermo Fisher Scientific Collaborates to Introduce Fully Automated Cell Line Automation Platform

Thermo Fisher and Celltrio bring first-in-kind automation platform to address critical scale-up challenges in biotherapeutics BURLINGTON, Ontario – (February 6, 2023) — Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture... Read more

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics research, disease biomarker discovery, drug discovery and development, and clinical trials leveraging pharmacoproteomics With Bruker investments, Biognosys plans to open advanced US proteomics CRO facility for proteomics biomarker and drug... Read more

Promoting Development and Commercialization of Innovative Technologies Through Collaboration Between Industry and AcademiaComprehensive Collaborative Agreement Signed with Kyoto University Aiming at Creating New Business Activities

Promoting Development and Commercialization of Innovative Technologies Through Collaboration Between Industry and AcademiaComprehensive Collaborative Agreement Signed with Kyoto University Aiming at Creating New Business Activities Read more

Hamilton and BioFluidiX head into the future together

Hamilton acquires the microdosing company BioFluidiX. The companies have an established partnership that will continue to grow under this agreement. November 21, 2022 – Hamilton announced today that it is expanding its microfluidics product range with the acquisition of the microdosing company, BioFluidiX. BioFluidiX’s patented microdosing processes enable precise dosing in the nano and picoliter... Read more